Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check10 days agoChange DetectedThe page gains new helper sections for reading the study record, joining the study, and answering common questions, and the recruitment status is updated to indicate no active enrollment; the revision label is updated to v3.6.0 and the Intervention/Treatment heading formatting is adjusted.SummaryDifference0.3%

- Check18 days agoChange DetectedThe page's revision indicator was updated from v3.5.4 to v3.5.5, marking a new version of the ClinicalTrials.gov study record.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an informational site release rather than a change to the clinical trial content.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check97 days agoChange DetectedRevision: v3.4.3 removed and Revision: v3.5.0 added.SummaryDifference0.0%

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.